Checkpoint Therapeutics Statistics
Total Valuation
CKPT has a market cap or net worth of $156.21 million. The enterprise value is $151.51 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CKPT has 45.02 million shares outstanding. The number of shares has increased by 92.62% in one year.
Current Share Class | 44.32M |
Shares Outstanding | 45.02M |
Shares Change (YoY) | +92.62% |
Shares Change (QoQ) | +18.14% |
Owned by Insiders (%) | 7.30% |
Owned by Institutions (%) | 9.26% |
Float | 33.41M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 214.29 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3,223.59 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.29
Current Ratio | 0.29 |
Quick Ratio | 0.26 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -633.94% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $2,043 |
Profits Per Employee | -$2.02M |
Employee Count | 23 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.71% in the last 52 weeks. The beta is 1.23, so CKPT's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | +69.71% |
50-Day Moving Average | 2.92 |
200-Day Moving Average | 2.24 |
Relative Strength Index (RSI) | 57.27 |
Average Volume (20 Days) | 1,020,097 |
Short Selling Information
The latest short interest is 5.56 million, so 12.36% of the outstanding shares have been sold short.
Short Interest | 5.56M |
Short Previous Month | 4.61M |
Short % of Shares Out | 12.36% |
Short % of Float | 16.65% |
Short Ratio (days to cover) | 5.70 |
Income Statement
In the last 12 months, CKPT had revenue of $47,000 and -$46.47 million in losses. Loss per share was -$1.01.
Revenue | 47,000 |
Gross Profit | -27.60M |
Operating Income | -37.51M |
Pretax Income | -52.32M |
Net Income | -46.47M |
EBITDA | n/a |
EBIT | -37.51M |
Loss Per Share | -$1.01 |
Full Income Statement Balance Sheet
Cash & Cash Equivalents | 4.70M |
Total Debt | n/a |
Net Cash | 4.70M |
Net Cash Per Share | $0.10 |
Equity (Book Value) | -12.59M |
Book Value Per Share | -0.27 |
Working Capital | -12.59M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -30.76M |
Capital Expenditures | n/a |
Free Cash Flow | -30.76M |
FCF Per Share | -$0.68 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -79,817.02% |
Pretax Margin | -98,868.09% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -58,872.06% |
Dividends & Yields
CKPT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -92.62% |
Shareholder Yield | -92.62% |
Earnings Yield | -29.75% |
FCF Yield | -19.69% |
Analyst Forecast
The average price target for CKPT is $12.00, which is 245.82% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.00 |
Price Target Difference | 245.82% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 6, 2022. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Dec 6, 2022 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
CKPT has an Altman Z-Score of -116.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -116.96 |
Piotroski F-Score | 2 |